Negative regulation of thymocyte apoptotic process

pathway activity — cross-omics
GO:0070244Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of thymocyte apoptotic process pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are RPL9P21, BUD31P2, and MAFTRR, each associated with the pathway in up to 3 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of thymocyte apoptotic process activity versus RPL9P21 in GBM (Pearson r = -0.28).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMRPL9P21 →+0.233+0.527.003.00733
COADBUD31P2 →+0.387+0.340<.001<.00133
UCECMAFTRR →+0.461+0.726.004<.00133
BRCAPTTG3P →+0.691+0.377.003.00333
OVLINC02269 →+0.191+0.566.005.00133
LSCCSNTG2-AS1 →+0.722+0.596.001.00933
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0070244 vs RPL9P21 — GBM

Per-sample scatter of Negative regulation of thymocyte apoptotic process activity vs RPL9P21 in GBM.

Explore this scatter interactively →

Exploration